对美国食品药品监督管理局（FDA）提议的用于局部用皮质类固醇生物等效性测试的剂量反应试验方法的评估。 - Suppr

Suppr

超能文献

Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

作者信息

Singh G J, Fleischer N, Lesko L, Williams R

出版信息

Pharm Res. 1998 Jan;15(1):4-7. doi: 10.1023/a:1011980115866.

DOI:10.1023/a:1011980115866

PMID:9487539

Abstract

摘要

相似文献

Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

Pharm Res. 1998 Jan;15(1):4-7. doi: 10.1023/a:1011980115866.

Revisiting FDA's 1995 Guidance on Bioequivalence Establishment of Topical Dermatologic Corticosteroids: New Research Based Recommendations.

J Pharm Pharm Sci. 2018;21(1):413-428. doi: 10.18433/jpps30021.

Bioequivalence Study Methods with Pharmacokinetic Endpoints for Topical Ophthalmic Corticosteroid Suspensions and Effects of Subject Demographics.

Pharm Res. 2018 Nov 15;36(1):13. doi: 10.1007/s11095-018-2537-8.

Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

Pharm Res. 1997 Mar;14(3):303-8. doi: 10.1023/a:1012089803281.

Transfer of the experimental methodology described in the FDA guidance for corticosteroid bioequivalence testing to pharmacodynamic effects caused by nicotinates.

J Cosmet Dermatol. 2006 Dec;5(4):289-93. doi: 10.1111/j.1473-2165.2006.00272.x.

Pharmacokinetic analysis of the FDA guidance for industry--'Topical dermatologic corticosteroids: in vivo bioequivalence'.

Eur J Pharm Biopharm. 2003 Jul;56(1):53-8. doi: 10.1016/s0939-6411(03)00045-6.

Application of the Food and Drug Administration (FDA) bioequivalent guidance of topical dermatological corticosteroid in yellow-skinned Japanese population: validation study using a chromameter.

J Dermatol. 2006 Oct;33(10):684-91. doi: 10.1111/j.1346-8138.2006.00159.x.

Bioequivalence of topical dermatological dosage forms--methods of evaluation of bioequivalence. AAPS/FDA Workshop on 'Bioequivalence of Topical Dermatological Dosage Forms-- Methods of Evaluating Bioequivalence', September 4-6, 1996, Bethesda, Md.

Skin Pharmacol Appl Skin Physiol. 1998 Mar-Apr;11(2):117-24. doi: 10.1159/000029817.

Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.

Clin Pharmacol Ther. 1999 Oct;66(4):346-57. doi: 10.1053/cp.1999.v66.a101209.

Bioequivalence (bioavailability) of generic topical corticosteroids.

J Am Acad Dermatol. 1989 May;20(5 Pt 1):791-6. doi: 10.1016/s0190-9622(89)70091-8.

本文引用的文献

Analysis of chromameter results obtained from corticosteroid-induced skin blanching. I: Manipulation of data.

Pharm Res. 1998 Feb;15(2):280-5. doi: 10.1023/a:1011926920834.

Evaluation of the proposed FDA pilot dose-response methodology for topical corticosteroid bioequivalence testing.

Pharm Res. 1997 Mar;14(3):303-8. doi: 10.1023/a:1012089803281.

Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies?

J Pharm Sci. 1996 Feb;85(2):232-9. doi: 10.1021/js950067y.

Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002.

'Vasoconstriction'--skin blanching--assay for glucocorticoids--a critique.

Arch Dermatol. 1989 Nov;125(11):1558-61. doi: 10.1001/archderm.125.11.1558.

Potency classification of topical corticosteroids: modern perspectives.

Acta Derm Venereol Suppl (Stockh). 1989;151:20-5; discussion 47-52.

Comparative blanching activities of proprietary diflucortolone valerate topical preparations.

Dermatologica. 1978;156(4):224-30. doi: 10.1159/000250920.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验